Dayton Suboxone Clinics

BrightView Centerville Addiction Treatment Center

BrightView Centerville Addiction Treatment Center
8120 Garnet Drive
Dayton, OH 45458

Phone: 866-928-5995
Website: www.brightviewhealth.com

Medication Types
Buprenorphine
Suboxone (buprenorphine / naloxone)
Vivitrol (naltrexone)

At BrightView Centerville Addiction Treatment Center, the outpatient model of our treatment program allows our staff to develop a unique treatment plan to work with our patients’ daily life commitments and individual needs. We accept Medicaid, Medicare, and most forms of insurance to make sure that anyone battling the disease of addiction can receive our treatment services. We have caring staff who answer the phones 24-hours per day, and we provide a toll-free phone number for the convenience of our patients.

BrightView’s compassionate and professional staff create an accessible and welcoming environment for both physical and emotional healing. We are about respect for each patient, positive reinforcement, and long-term wellness. If you are looking for a patient-centered recovery center, we encourage you to take the first step in contacting us today.

 

Join Here To Have Your Medical Practice Featured in this space

Following payment completion, please send us the listing information you would like displayed here.

methadone8c

Dayton is home to numerous physicians approved to write prescriptions for buprenorphine for opioid addiction and related withdrawal symptoms. Buprenorphine is the active ingredient in suboxone which alleviates opiate withdrawal symptoms like chills, diarrhea, nausea, and vomiting. Doctors approved to write suboxone prescriptions have taken training in the safe administration of suboxone. Suboxone has garnered a favorable reputation in the medical community due to its good safety profile and its demonstrated usefulness in eliminating opioid withdrawal sickness. If you are a local physician who treats Dayton area residents, you may purchase a featured listing at the top of this page insuring that your medical services will be found by prospective patients searching our website for quality opioid treatment. Buprenorphine has emerged as an excellent therapeutic option for opioid addicted persons, and Methadone.US is working to educate the general public on the variety of treatment alternatives available in their locality.



Dayton Buprenorphine Suboxone Doctors
Marlon DeMarcie Twyman, M.D. 1152 West Third Street
Dayton, OH 45402
(937) 268-3483
Morris Lamar Brown, M.D. 301 West First
Dayton, OH 45402
(937) 461-0800
Ugo Nwokoro, M.D. 1 Elizabeth Place
Suite 260
Dayton, OH 45408
(937) 224-4325
Amita R. Patel, M.D. Dayton Psychiatric Associates
627 Edwin C. Moses Blvd., 5th Fl., Ste K
Dayton, OH 45408
(937) 424-1000
Bhimavarapu K. Reddy, M.D. Dayton Pain Center, LLC.
One Elizabeth Place
Dayton, OH 45408
(937) 222-2233
Jan Jack Gouda, M.D. 1 Elizabeth Place
Suite D
Dayton, OH 45417
(937) 222-2233
Michael Benjamin Dulan, M.D. 1133 Edwin C Moses Boulevard
Suite 340
Dayton, OH 45417
(888) 440-0982
Leroy Goodson, M.D. 1 Elizabeth Place
Suite D
Dayton, OH 45417
(937) 723-8185
Srinivas Erragolla, M.D. Dayton Pain Center, LLC
1 Elizabeth Place, Suite D
Dayton, OH 45417
(937) 222-2233
Gideon Sunday Adebisi Adegbile, M.D. 1800 North James H. McGhee Boulevard
Dayton, OH 45417
(937) 262-3500
Lisa F. Lichota, D.O. 1074 Patterson Road
Dayton, OH 45420
(937) 254-3988
Arvin K. Nanda, M.D. 3328 South Smithville Road
Dayton, OH 45420
(937) 254-5661
Florence Squire Coleman, M.D. VA Medical Center
4100 West Third Street
Dayton, OH 45428
(937) 268-6511×2167
Ramakrishna Gollamudi, M.D. 4100 West 3rd Street
Dayton, OH 45428
(937) 268-6511 x1314
Charles Lee Walters, M.D. Dayton VA Medical Center
4400 West Third Street, MHC
Dayton, OH 45428
(937) 262-2186
Sarita Mahajan, M.D. 4100 West Third Street
Dayton, OH 45428
(937) 262-2167
Julia I. Lucente, M.D. Dayton VA Medical Center
4100 West Third Street
Dayton, OH 45428
(937) 344-4450
Saira Khalid Khan, M.D. 4124 Linden Avenue
Dayton, OH 45432
(937) 716-2700
W. H. Donahue, D.O. 1010 Woodman Drive
Dayton, OH 45432
(937) 228-2032
Abdul Q. Shahid, M.D. 1010 Woodman Drive
Dayton, OH 45432
(937) 252-2000
Gulam Jeelani Mukhdomi, M.D. 1010 Woodman Drive
Dayton, OH 45432
(937) 252-2000
Suresh Gupta, M.D. 1010 Woodman Drive
Dayton, OH 45432
(937) 252-2000
Pravesh B. Patel, M.D. 1520 Germantown Street
Dayton, OH 45434
(937) 222-8111
Darshan Singh, M.D. 1320 Woodman Drive
Suite 200
Dayton, OH 45434
(937) 223-1781
Rick T. Bowers, M.D. 3095 Kettering Boulevard
Dayton, OH 45439
(937) 293-8300

Federal Rules For Methadone Access Are Changing

The synthetic opioid, fentanyl, has led to an increase in overdose deaths in recent years. As many as 112,000 in the last year according to NPR. As a result, some physicians are pushing to make methadone more available to those who need it.

The Biden administration has created new federal rules for methadone treatment designed to widen access for more patients. In particular, the requirement of one year of active opioid addiction is being reduced to just 6 months of opioid addiction in order to become eligible to receive methadone.

There are about 2000 federally-approved opioid treatment programs (OTP) in the United States. Many thousands of patients are receiving life saving services from these clinics. Since COVID, many OTP clinics have made take home medication more accessible to those in early phases of treatment.

With illegal opiates still flooding the country, increasing access to opioid treatment and medication is easily justified. The question remains as to how local law enforcement can ultimately stem the flow of drugs into the community, as well as how youth can be educated to avoid risking first drug use.

Posted in Buprenorphine, Harm Reduction, Methadone, Methadone Clinics, Methadone Take Home, Opioid Treatment, Prescription Drugs, Suboxone | Tagged , | Comments Off on Federal Rules For Methadone Access Are Changing

How Bad Is Opioid Withdrawal

There is an informative video by Sarah Wakeman on the physical and psychological perils of severe opioid withdrawal. Sarah is a Medical Director at Mass General Brigham. They are an integrated health care system that conduct medical research, teaching, and patient care.

In the video, Sarah explains how opioid withdrawal can become so severe with diarrhea and vomiting that individuals can die from extensive dehydration. As physicial dependency progresses, the brain becomes increasingly imbalanced and unable to function without the presence of opioids.

When opioid withdrawal commences (usually 8-12 hours after last use), it becomes increasingly unbearable as the body is flushed with stress hormones. The withdrawal discomfort builds in intensity over days, and can last up to a week or more. For many, this withdrawal process feels akin to a severe case of the flu, but then potentially reaches levels of sickness even far beyond that.

In the video, Sarah goes on to discuss the benefits of methadone and buprenorphine in reducing severe withdrawal symptoms and in helping patients to ultimately not die from overdose. She also illuminates on how rational decision-making is so extremely difficult when struggling against the intense pain of opioid withdrawal.

Please check this video out, and share it with anyone you believe can benefit from its message.

Posted in Buprenorphine, Medication Assisted Treatment, Methadone, Methadone Clinics, Opiate Withdrawal, Opioid Treatment, Pain Management, Prescription Drugs, Suboxone | Tagged | Comments Off on How Bad Is Opioid Withdrawal

Helping Skeptics Understand Methadone

When it comes to addiction, reactions and opinions are often intense. Addiction is a devastating illness that can rapidly derail a person’s life, and seriously impact the lives of those around them.

Sadly, addiction leads people to behave in ways that make no sense to their family, friends, and co-workers. Therein lies an important part of the problem. Family feel confused, angry, and fearful as their loved one tumbles down the hill of active addiction.

When it comes to something as perplexing as drug addiction, grasping for answers is an understandable reflex for family and friends. What family often don’t comprehend is the power of physical dependency to opioids and the severe sickness that results from opioid withdrawal.

Family and others incorrectly assume that mere “choice” is all that’s needed to overcome the addiction. When the addict fails to remain drug free, harsh judgment by others usually follows.

Halting withdrawal sickness is a paramount step for an opioid addicted person. This cannot be overstated. As long as a person is suffering from severe opioid withdrawal, their ability to think and “choose” logically is greatly impaired.

Statistically, individuals who utilize medication-assisted treatment (like methadone) are far more likely to avoid incarceration, a continued downward spiral, or death by overdose. Medication assistance successfully removes debilitating withdrawal sickness so that the addicted person can experience greater clarity of thought and the ability to make more sound decisions that lead to improved quality of life.

If you are a skeptic about methadone or suboxone, you may think “they’re just trading one drug for another”. This is not true. People, once therapeutically stabilized on methadone or suboxone, do not get high from the medication. Health generally improves, and the person is able to function much better on the job and at home. This brings hope. It offers a new opportunity for further recovery.

When you care about a person’s survival, one more chance to help them can be quite valuable. Don’t let judgment or excessive skepticism get in the way. Medication-assistance in opioid recovery is effective for many people, and it has been the life saving next step that some never got the chance to take.

Posted in Methadone, Methadone Benefits, Methadone Clinics, Recovery, Suboxone | Tagged | Comments Off on Helping Skeptics Understand Methadone

Methadone Treatment in Oregon

Like most states, Oregon is in need of quality treatment options for opioid-addicted individuals who are ready for recovery.

This article, in the Hillsboro News-Times, features the recent approval by Washington County commissioners to add a new methadone clinic in Hillsboro, Oregon.

Acadia Healthcare is aiming to establish the new methadone clinic in Hillsboro in order to better serve the local community. Acadia already operate a mobile unit in the general area as well as a comprehensive treatment center (CTC) in nearby Tigard located about 20 miles away.

The commissioners voted 5-0 to approve the proposed site which will be on the local bus route thereby providing improved access. The article mentions that Oregon presently has 17 operational methadone clinics serving the state, where fentanyl, opiates, and other substances are causing a grave overdose crisis.

Having local opioid treatment available is a critically important step in saving lives and providing hope to patients and families. Methadone has been proven to decrease opioid use, reduce relapse risks & overdose deaths, as well as increase employment and overall health. Clinics offering medication-assisted treatment (MAT), like methadone and buprenorphine, are forging a new path to safety for those people once stuck in active addiction.

Posted in Acadia Healthcare, Addiction Treatment, Buprenorphine, Methadone, Methadone Clinics, Oregon Methadone Clinics, Suboxone | Tagged , , | Comments Off on Methadone Treatment in Oregon

For several decades, opioid use disorder has emerged in the U.S. as a primary medical problem that has affected millions of lives. People from culturally different backgrounds have all been impacted by the dangers of opioid misuse and opioid dependence. However, addiction is a treatable illness whose progression can be halted through participation in a recovery process. With opioid addiction in particular, the recovery process can be greatly aided through the use of medication-assistance like that offered with buprenorphine and suboxone. Buprenorphine is the active ingredient in suboxone and subutex. Years of research has demonstrated the essential role that buprenorphine-based medications can play in stabilizing patients who are suffering with opioid withdrawal symptoms.